{"id":16115,"date":"2013-01-17T01:30:00","date_gmt":"2013-01-17T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/industria-farmaceutica-la-reputazione-precipita-nel-2012\/"},"modified":"2013-01-17T01:30:00","modified_gmt":"2013-01-17T00:30:00","slug":"industria-farmaceutica-la-reputazione-precipita-nel-2012","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/industria-farmaceutica-la-reputazione-precipita-nel-2012\/","title":{"rendered":"Pharmaceutical industry, reputation plummets in 2012"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 0pt\"><font face=\"Calibri\"><span style=\"font-family: OpenSansLightRegular; color: #666666; font-size: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">marted&igrave; 15 gennaio 2013<\/span><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 0cm 0cm 10pt\"><font face=\"Calibri\"><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">Of <\/span><b><span lang=\"EN\" style=\"font-family: OpenSansLightRegular; color: #333333; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN\"><a href=\"http:\/\/www.aboutpharma.com\/autore\/9169a0ee-2bab-42ba-b667-e7a5d7b680b5\/marco-giorgetti\/\" target=\"_blank\" rel=\"noopener\"><span lang=\"IT\" style=\"color: #333333; text-decoration: none; mso-ansi-language: IT; text-underline: none\">Marco Giorgetti<\/span><\/a><\/span><\/b><\/font><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><br \/> <\/span><span lang=\"EN\" style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN\"><a href=\"http:\/\/www.aboutpharma.com\/aboutpharma\/\" target=\"_blank\" rel=\"noopener\"><span lang=\"IT\" style=\"color: #333333; text-decoration: none; mso-ansi-language: IT; text-underline: none\"><font face=\"Calibri\">AboutPharma and Medical Devices<\/font><\/span><\/a><\/span><span style=\"font-family: OpenSansLightRegular; color: #595959; font-size: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 15pt; mso-outline-level: 2; mso-line-height-alt: 13.5pt\"><span style=\"font-family: OpenSansLightRegular; font-size: 15pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"><font face=\"Calibri\">Il report di Patient View: i profitti vengono prima della salute dei pazienti <\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: 13.5pt; margin: 7.5pt 0cm\"><font face=\"Calibri\"><span style=\"font-family: OpenSansLightRegular; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\">La reputazione del farmaceutico? In caduta libera. Un&#8217;emergenza che rappresenter&agrave; uno dei temi forti del 2013, sul quale <i>AboutPharma <\/i>ha gi&agrave; acceso i riflettori attraverso il <\/span><span lang=\"EN\" style=\"font-family: OpenSansLightRegular; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT; mso-ansi-language: EN\"><a target=\"_blank\" href=\"http:\/\/aboutpharma.com\/in-edicola\/riviste\/aboutpharma\/n-104-aboutpharma-and-medical-devices\/\" rel=\"noopener\"><b><i><span lang=\"IT\" style=\"color: windowtext; text-decoration: none; mso-ansi-language: IT; text-underline: none\">mensile di gennaio<\/span><\/i><\/b><\/a><\/span><span style=\"font-family: OpenSansLightRegular; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: IT\"> e non solo (vai alla nostra news sull&rsquo;<\/span><span","protected":false},"excerpt":{"rendered":"<p>marted&igrave; 15 gennaio 2013 di Marco Giorgetti AboutPharma and Medical Devices Il report di Patient View: i profitti vengono prima della salute dei pazienti La reputazione del farmaceutico? In caduta libera. Un&#8217;emergenza che rappresenter&agrave; uno dei temi forti del 2013, sul quale AboutPharma ha gi&agrave; acceso i riflettori attraverso il mensile di gennaio e non &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16115","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16115"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16115\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}